Given that antisense transcripts have been shown to silence genes in diseases including cancer (34,35) and that EST annotations indicate the potential for large antisense transcripts in this region, we investigated whether LCT13 transcripts originating at the L1-ASP could act as antisense transcripts to TFPI-2. The gene discussed is TFPI2; the disease is cancer.